Drug intelligence / Profile preview

Emune Plus

Development stage
Discontinued
Lead developer
Parnasa Mediworld
Modality
Small Molecules
Administration
Oral
01

Overview

Emune Plus is a nutraceutical or Ayurvedic proprietary medicine developed by Parnasa Mediworld. It is typically formulated as a combination of herbal extracts, most notably *Carica papaya* (papaya leaf) and *Tinospora cordifolia* (Giloy). The product is primarily indicated as an immunomodulator and for the management of thrombocytopenia (low platelet count), often associated with viral infections such as Dengue fever. *Carica papaya* extract is believed to stimulate platelet production by enhancing the activity of enzymes involved in megakaryocyte formation and upregulating the ALOX12 gene. *Tinospora cordifolia* contributes to the formulation's therapeutic profile through its immunomodulatory properties, which include the stimulation of macrophage activity. Although previously listed in the developer's pipeline or product catalog, recent information suggests the product may have been discontinued or is no longer actively marketed by the company.

Brand names
Emune Plus
Other names
Emune Plus-Parnasa Mediworld
02

Targets

TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on Emune Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emune Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call